This is an over the counter product - it does not require prescription.Bio Case V Tablets
A digestive pancreatic intestinal aid used in replacement therapy where digestion
of protein, carbohydrate and fat is inadequate. Contains a pancreatic enzyme concentrate
of porcine origin.
Bio Case-V is activated whole raw pancreas; a pancreatic enzyme concentrate
of porcine origin containing standardized amylase, protease and lipase activities
plus esterases, peptidases, nucleases and elastase.
A review of the literature over the past 20 years, together with clinical experience,
prompts the conclusion that pancreatitis is an important disease in the dog.
Evidence of the disease was observed in approximately 3% of a series of dogs
necropsied at the Angell Memorial Animal Hospital. Others have classified disease
of the pancreas into 4 distinctive categories: acute necrotic pancreatitis;
subacute or chronic pancreatitis; pancreatic fibrosis; and collapse or atrophy
of the acinar pancreatic tissue. Only acute and chronic pancreatitis is readily
Dogs that acquire acute pancreatitis usually recover, but are subject to exacerbations
of the chronic inflammatory process that may persist. Complete healing of the
acute lesion may not occur, and progressive destruction of the gland may take
place over a period of months, even in the absence of clinical signs.
Chronic pancreatitis is characterized by acute exacerbations of pancreatic
inflammation that occur after the remission of acute pancreatitis. Signs of
the disease are similar to those of acute pancreatitis but are usually less
Steatorrhea, diarrhea, weight loss and increased appetite characterize the
digestive impairment caused by failure of pancreatic exocrine secretion. Secretion
ceases when the acinar tissue is destroyed in the course of chronic pancreatitis.
This sequela does not become evident until virtually total destruction of the
acinar pancreas has occurred, because as little as 12 to 20 percent of the exocrine
pancreas can secrete enough pancreatic juice to sustain digestion. Thus, digestive
impairment is a relatively late event in the pathogenesis of chronic pancreatitis.
Transient episodes of fetid diarrhea may occur at the time of an acute exacerbation,
and may be caused by a temporary reduction of pancreatic exocrine secretion.
However, food engorgement or the ingestion of fatty food often precipitates
an exacerbation of chronic pancreatitis and the character of the food, rather
than the absence of pancreatic enzymes, may cause the diarrhea.
The veterinarian should not be too concerned about whether the pancreatic lesion
is acute or chronic. Their primary concern should be to recognize pancreatic
inflammatory disease and begin treatment. The differentiation of acute and chronic
pancreatitis is then made on the basis of history, and is of importance in advancing
As a digestive aid; replacement therapy where digestion of protein, carbohydrate
and fat is inadequate due to exocrine pancreatic insufficiency.
Discontinue use in animals with symptoms of sensitivity.
TREATMENT IN ACUTE AND CHRONIC PANCREATITIS
The most important aspect of the treatment of acute pancreatitis is initiation
of vigorous therapy aimed at combating pain and shock, restoring blood volume,
blood pressure and renal function, with reducing pancreatic secretions and combating
secondary infection of necrotic tissue. Animals surviving an acute attack should
be placed on a bland and easily digested diet (such as Prescription Diet®,
i/d) and supplemented with Bio Case-V.
In chronic pancreatitis, replacement therapy must be given for the duration
of the animal's life. Three daily feedings of a bland and easily digested diet
containing sufficient quantities of good quality proteins and carbohydrates
and low levels of fat are recommended (i.e., Prescription Diet, i/d). Bio-Case-V
is given with each meal at a dosage level sufficient to keep the feces normal.
ADMINISTRATION AND DOSAGE
The Bio Case-V capsules are administered before each meal. Bio Case-V powder
is added to moistened dog food (canned or dry). Thorough mixing is necessary
to bring the enzymes into close contact with the food particles. Incubation
at room temperature for 15-20 minutes before feeding appears to enhance the
digestive process. Frequent feeding, at least 3 times daily, is important.
Dogs: 2-3 tablets or ¾-1 teaspoonful (2.8 g/teaspoonful) with each meal.
Cats: ½-1 tablet or ¼-¾ teaspoonful (2.8 g/teaspoonful)
with each meal.
NOTE: No one regimen will be successful for every patient. The above dosage
should be adjusted according to the severity of the pancreatic exocrine deficiency
and weight of the animal. In cases of chronic insufficiency, the dosage should
be increased until desired results are obtained.
Each capsule contains sufficient pancreatic enzymes to digest (in vitro):
- 33 g fat
- 57 g protein
- 64 g starch.
Each capsule contains:
- Lipase: 10,150 USP units
- Protease: 77,500 USP units
- Amylase: 88.392 USP units